Indian Journal of Cancer Home 

SYMPOSIUM
[View FULLTEXT] [Download PDF]
Year : 2009  |  Volume : 46  |  Issue : 2  |  Page : 88--95

Current concepts and newer developments in the treatment of malignant gliomas

SB Omay, MA Vogelbaum 
 Cleveland Clinic Brain Tumor and Neuro-Oncology Center, 9500 Euclid Avenue, Cleveland, OH 441 95, USA

Correspondence Address:
M A Vogelbaum
Cleveland Clinic Brain Tumor and Neuro-Oncology Center, 9500 Euclid Avenue, Cleveland, OH 441 95
USA

Primary malignant brain tumors account for only 2% of all adult cancers but they cause a disproportionately high cancer-related disability and death. Survival of malignant glioma patients has changed only modestly over the past three decades despite the emergence of new treatment strategies for these tumors. In this review, we describe the standard treatment modalities for malignant glioma, which include surgery, radiation therapy and chemotherapy, as well as the status of novel therapies that have been developed to target various aspects of glioma cell biology. We also address this issue of drug delivery as a factor limiting the efficacy of systemic administration of therapeutics and attempts to overcome this barrier. Further progress towards a cure for malignant gliomas will require a greater understanding of the underlying mechanisms driving the growth, and resistance to therapy, of these challenging tumors.


How to cite this article:
Omay S B, Vogelbaum M A. Current concepts and newer developments in the treatment of malignant gliomas.Indian J Cancer 2009;46:88-95


How to cite this URL:
Omay S B, Vogelbaum M A. Current concepts and newer developments in the treatment of malignant gliomas. Indian J Cancer [serial online] 2009 [cited 2020 Aug 6 ];46:88-95
Available from: http://www.indianjcancer.com/article.asp?issn=0019-509X;year=2009;volume=46;issue=2;spage=88;epage=95;aulast=Omay;type=0